Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verde Science Inc VRCI

Healthcare Biotechnology
Verde Science, Inc. is a pharmaceutical research and development company. The Company is engaged in medical science consulting business. The Company is focused on the discovery of drugs and treatment modalities, as well as diagnostic devices and pharmaceutical delivery systems for the treatment of diseases and medical issues. The Company is focused on developing medicinal formulations from cannabinoids and tetrahydrocannabinol (THC) compounds for the treatment of various issues, such as migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues. The Company is focused on launching its THC Pharmaceutical Development Program by executing a research program, which involves developing formulations preparing protocols for clinical trials.


GREY:VRCI - Post by User

Verde Science Inc
<< Previous
 Bullboard Posts
User Avatar Image
(266)
•••
Post by jimrockfordon Nov 16, 2014 3:23pm
297 Views
Post# 23134139

RTB / MMPR Comparables

RTB / MMPR ComparablesCompany          -                 Market Cap                      -                Status
 

Abattis          -            $10.4 million                 -            Awaiting the RTB Letter 
Affinor          -             $17 million                 -            Await HC licenses, approvals


Matica          -             $5.6 million          -             RTB- and inspection date set with HC for MMPR
Supreme Pharm.   -    $25.2 million                -         Pre-approval from HC
Prescient     -              $60 million plus (halted)   -    RTB 



Organigram       -        $54.1 million                     -    MMPR
Bedrocan          -         $53.3 million                    -     MMPR – importing cannabis           
                                                                                  Building Canadian facility             
Mettrum            -        $59.3 million                     -     MMPR
Tweed               -         $102.7 million                 -      MMPR
T-Bird Pharma   -         $23 million                      -     MMPR - but very small



<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities